Article
A four‐gene‐based model predicts TACE efficacy for hepatocellular carcinoma patients
2022-03-03
Abstract excerpt
<h4>Background: </h4> Primary liver cancer, of which hepatocellular carcinoma (HCC) accounts for over 90%, is the sixth most common cancer and the fifth leading cause of cancer mortality worldwide. Transcatheter arterial chemoembolization (TACE) is widely performed globally as an effective treatment for HCC patients at intermediate and advanced stages, but the efficiency varies amongst patients. Objective This st...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 165085e0-3098-53da-8277-29f91eb9d247
- DOI
- 10.21203/rs.3.rs-1353233/v1
